Details
Stereochemistry | ACHIRAL |
Molecular Formula | C13H11NO2 |
Molecular Weight | 213.2319 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
OC1=C(C=CC=C1)C(=O)NC2=CC=CC=C2
InChI
InChIKey=WKEDVNSFRWHDNR-UHFFFAOYSA-N
InChI=1S/C13H11NO2/c15-12-9-5-4-8-11(12)13(16)14-10-6-2-1-3-7-10/h1-9,15H,(H,14,16)
Salicylanilide (Salinidol). It is anilide of salicylic acid. It is an antifungal agent useful in the treatment of tinea capitis. Due to its inritant action on the skin, the concentration used should be 5 per cent or less. Salicylanilide is an oxidative phosphorylation uncoupler. Salicylanilide inhibits mycobacterial isocitrate lyase. Shows antifungal, antimycobacterial and antihelmitic effects in vivo.
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: CHEMBL1667699 |
|||
Target ID: CHEMBL2111188 Sources: https://www.ncbi.nlm.nih.gov/pubmed/24953953 |
Conditions
Condition | Modality | Targets | Highest Phase | Product |
---|---|---|---|---|
Primary | Salinidol Approved UseTinea capitis Launch Date-7.5746882E11 |
PubMed
Title | Date | PubMed |
---|---|---|
Antimycobacterial and antifungal isosters of salicylamides. | 2003 Aug |
|
Relationship between the structure and antimycobacterial activity of substituted salicylanilides. | 2003 Mar |
|
Small molecules with antimicrobial activity against E. coli and P. aeruginosa identified by high-throughput screening. | 2006 Nov |
|
Myelin vacuolation, optic neuropathy and retinal degeneration after closantel overdosage in sheep and in a goat. | 2007 Feb-Apr |
|
Assessment of the solid-state composition of an active salicylanilide compound by FT-Raman spectroscopy. | 2007 May 9 |
|
Protein and Peptide drug delivery: oral approaches. | 2008 May-Jun |
|
Identification of 14-3-3zeta by chemical affinity with salicylanilide inhibitors of interleukin-12p40 production. | 2008 Sep |
|
Salicylanilides: selective inhibitors of interleukin-12p40 production. | 2008 Sep 15 |
|
2-Hydr-oxy-3-nitro-N-phenyl-benzamide. | 2009 Apr 18 |
|
A novel method for oral delivery of apolipoprotein mimetic peptides synthesized from all L-amino acids. | 2009 Aug |
|
Salicylanilide esters of N-protected amino acids as novel antimicrobial agents. | 2009 Jan 15 |
|
Drug discovery for schistosomiasis: hit and lead compounds identified in a library of known drugs by medium-throughput phenotypic screening. | 2009 Jul 14 |
|
Multi-residue determination of phenolic and salicylanilide anthelmintics and related compounds in bovine kidney by liquid chromatography-tandem mass spectrometry. | 2009 Nov 13 |
|
Salicylanilide carbamates: antitubercular agents active against multidrug-resistant Mycobacterium tuberculosis strains. | 2010 Feb |
|
Polioencephalomalacia associated with closantel overdosage in a goat. | 2010 Jun |
|
Salicylanilide derivatives block Mycobacterium tuberculosis through inhibition of isocitrate lyase and methionine aminopeptidase. | 2012 Sep |
Patents
Sample Use Guides
Tinea capitis treatment: the concentration used should be 5 per cent or less.
Route of Administration:
Topical
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/24953953
Salicylanilide inhibited Mycobacterium tuberculosis H37Rv 331/88 (assessed as complete growth inhibition after 14 days) with MIC 32uM.
Name | Type | Language | ||
---|---|---|---|---|
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Code | English | ||
|
Brand Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
EPA PESTICIDE CODE |
77407
Created by
admin on Fri Dec 15 15:03:59 UTC 2023 , Edited by admin on Fri Dec 15 15:03:59 UTC 2023
|
||
|
NCI_THESAURUS |
C28394
Created by
admin on Fri Dec 15 15:03:59 UTC 2023 , Edited by admin on Fri Dec 15 15:03:59 UTC 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
SALICYLANILIDE
Created by
admin on Fri Dec 15 15:03:59 UTC 2023 , Edited by admin on Fri Dec 15 15:03:59 UTC 2023
|
PRIMARY | |||
|
6872
Created by
admin on Fri Dec 15 15:03:59 UTC 2023 , Edited by admin on Fri Dec 15 15:03:59 UTC 2023
|
PRIMARY | |||
|
m9737
Created by
admin on Fri Dec 15 15:03:59 UTC 2023 , Edited by admin on Fri Dec 15 15:03:59 UTC 2023
|
PRIMARY | Merck Index | ||
|
239133
Created by
admin on Fri Dec 15 15:03:59 UTC 2023 , Edited by admin on Fri Dec 15 15:03:59 UTC 2023
|
PRIMARY | |||
|
C84142
Created by
admin on Fri Dec 15 15:03:59 UTC 2023 , Edited by admin on Fri Dec 15 15:03:59 UTC 2023
|
PRIMARY | |||
|
DTXSID7021784
Created by
admin on Fri Dec 15 15:03:59 UTC 2023 , Edited by admin on Fri Dec 15 15:03:59 UTC 2023
|
PRIMARY | |||
|
201-727-8
Created by
admin on Fri Dec 15 15:03:59 UTC 2023 , Edited by admin on Fri Dec 15 15:03:59 UTC 2023
|
PRIMARY | |||
|
C034596
Created by
admin on Fri Dec 15 15:03:59 UTC 2023 , Edited by admin on Fri Dec 15 15:03:59 UTC 2023
|
PRIMARY | |||
|
3539
Created by
admin on Fri Dec 15 15:03:59 UTC 2023 , Edited by admin on Fri Dec 15 15:03:59 UTC 2023
|
PRIMARY | |||
|
100000170194
Created by
admin on Fri Dec 15 15:03:59 UTC 2023 , Edited by admin on Fri Dec 15 15:03:59 UTC 2023
|
PRIMARY | |||
|
salicylanilide
Created by
admin on Fri Dec 15 15:03:59 UTC 2023 , Edited by admin on Fri Dec 15 15:03:59 UTC 2023
|
PRIMARY | |||
|
87-17-2
Created by
admin on Fri Dec 15 15:03:59 UTC 2023 , Edited by admin on Fri Dec 15 15:03:59 UTC 2023
|
PRIMARY | |||
|
14881
Created by
admin on Fri Dec 15 15:03:59 UTC 2023 , Edited by admin on Fri Dec 15 15:03:59 UTC 2023
|
PRIMARY | |||
|
LHP8NEY345
Created by
admin on Fri Dec 15 15:03:59 UTC 2023 , Edited by admin on Fri Dec 15 15:03:59 UTC 2023
|
PRIMARY | |||
|
CHEMBL82970
Created by
admin on Fri Dec 15 15:03:59 UTC 2023 , Edited by admin on Fri Dec 15 15:03:59 UTC 2023
|
PRIMARY | |||
|
SUB184004
Created by
admin on Fri Dec 15 15:03:59 UTC 2023 , Edited by admin on Fri Dec 15 15:03:59 UTC 2023
|
PRIMARY |
ACTIVE MOIETY